雷霆天心

$VZ 交出“转型一年”的答卷：三季度营收 343 亿微增 1.5%，净利润 53 亿、调整后每股收益 1.31 美元增 8.3%，调整后 EBITDA 138 亿创纪录、利润率升至 40.2%。客户面亮点突出：后付费手机净增 40.6 万（同比增逾 8 倍、五年最佳三季度），后付费账户净增 13.7 万为十余年最佳，获客促销成本降 41%。公司连续第三季上调全年指引，调整后 EPS 看 5.04–5.06。更受关注的是一桩新交易：与 AWS 签下价值 20 亿美元以上的分布式算力框架，为其光纤网络承接生成式与智能体 AI 负载——此前已与谷歌签下 10 亿美元级暗光纤协议。但股价开盘仅约跌 2%，说明市场尚未为“电信变 AI 基建”的叙事买单。当补贴退潮、忠诚客接棒，这门慢生意的估值重构才刚开头。

$RCL 三季度上调全年指引、股价涨逾 8%，但燃油正悄悄分走一部分红利。基本面，营收约 56 亿同比增 9%，载客 270 万人次增 9%、载客率 112%，调整后每股收益 6.57 美元（预期 6.38），并把 2026 年调整后 EPS 抬到 17.85–17.95。需求面相当扎实：欧洲与加勒比临期预订强于预期，2027 年航次预订量以高双位数领先历史节奏，复购客接近半数。成本面则要打折扣：净巡航成本（除燃油）降 1.9% 部分因费用平移至四季度，并非纯效率；全年燃油开支约 13.45 亿、四季度约 3.79 亿，58% 套保只提供部分保护。资金面，公司宣布收购 Sandals/Beaches 五成权益（约 30 亿度假村交易），2027 年起并表贡献。强劲的度假需求，能盖过油价与费用平移的双重挤压吗？

$BA has a record backlog of $745 billion, yet its stock plunged about 10% in a single day. The market is focused on just one thing: the 737 MAX production ramp. Third-quarter revenue rose 4% year over year to $24.2 billion, while net losses narrowed to $116 million (compared with a $5.3 billion loss in the same period last year, largely due to a 777X charge). Commercial airplane deliveries hit 161, the highest since 2018, and Defense revenue climbed 15% to $7.9 billion. The financial picture is actually improving: free cash flow was $464 million, up from $238 million a year earlier, and Boeing laid out its first multiyear targets—about $2 billion in 2026 and a push toward $10 billion in 2029. But management has pushed back its target of stabilizing production at 47 planes a month to early 2027, with the move to 52 a month now delayed until the second half of 2027. Full-year deliveries will fall short of the 500-plane target. The post-wing production stage in Renton is the bottleneck. The 737-7 and 737-10 may have received FAA certification, but the production ramp won’t be linear. With a near-record backlog on one side and a far-off cash-flow trajectory on the other, which do you believe in more: the backlog or the production ramp?

$UPS 三季度交出了“量不增、利却厚”的答卷：综合营收 229 亿美元同比增 6.7%，看似温和，但驱动结构值得细看。美国国内件量几乎持平，增长全靠单件收入提升 6.1% 拉动；国际单件收入更涨 15.0%，供应链解决方案营收增 18.2%（医疗与货运为主）。盈利面，非 GAAP 调整后摊薄每股收益 1.69 美元，公司顺势把全年营收指引抬到约 926 亿、调整后自由现金流抬到约 61 亿。资金与效率面，公司已完成与亚马逊低质件量的“滑落”、网络自动化压低单位成本，premium mix 取代 volume 成为利润引擎。但供应链解决方案因商誉减值，经营利润率被压到 3.1%，提示转型仍带阵痛。当电商件量见顶，靠提价和自动化撑起的利润能走多远？

According to Bloomberg, semiconductor company $MRVL is in advanced talks to acquire data-center optical components maker Lumentum ($LITE ), with a deal announcement possible as early as next week, though the talks could still fall apart. $MRVL has a market capitalization of about $221 billion, while $LITE is worth about $83 billion. If completed, the deal would rank among the largest tech acquisitions in history. The market’s initial reaction was typical: the buyer’s shares fell about 8%–9% after hours, while the target’s rose about 9%–11%. The pressure on the buyer is easy to understand: it has less than $4 billion in cash, and swallowing a target worth nearly $83 billion would almost certainly require a combination of stock issuance and borrowing. That would add integration risks and fuel doubts that it is “buying at the peak of the AI cycle.” Meanwhile, the seller is being labeled expensive, despite having already booked orders for its products through 2029 and being on track to more than double its revenue this year. What makes this deal unusual is the buyer’s desire to fill gaps in its in-house photonics capabilities and bring chip design and the optical-module supply chain under one roof. The question is whether $MRVL is positioning itself for the next phase of AI infrastructure—or laying the groundwork for impairment losses from a peak-priced acquisition.

$LH reported third-quarter revenue of $3.81 billion, up 6.9% year over year, and adjusted EPS of $4.78, up a robust 14.5%. Both beat expectations, prompting the company to raise its full-year revenue growth guidance by about 50 basis points and the midpoint of its adjusted EPS guidance by 18 cents. On the surface, this looks like a familiar story of “profits growing much faster than revenue.” But another factor is helping drive the upgrade: acquisitions. The company finalized four deals this quarter and afterward—MLM Medical Labs, certain BioReference assets, Myriad’s prenatal testing business, and Millennium Health—and says each will boost adjusted EPS in its first year and recoup its cost of capital within three years. Operating margins expanded in both Diagnostics and Biopharma, reaching 16.7% and 18.3%, respectively, suggesting that cost-cutting is indeed taking hold. But as growth increasingly depends on assets acquired from outside, the quality of this “upgrade” deserves closer scrutiny. Which matters more to you: organic margin growth or the pace of expansion through acquisitions?

$WING’s latest quarterly numbers are a mixed bag: revenue totaled $185.1 million, up 5.3% year over year, but same-store sales fell 5.4%—the second consecutive quarter of decline. Domestic sales per store dropped from $2.06 million to $1.85 million. In other words, nearly all revenue growth came from the 76 new restaurants, while traffic at established locations continued to erode. Yet the stock closed up about 12% that day. The reason wasn’t revenue, but earnings per share: adjusted EPS of $1.08 beat consensus by 6 cents, with roughly $288 million in buyback capacity providing support and management signaling early progress in its turnaround. This looks more like a rally driven by repricing the stock on a per-share earnings basis, while temporarily overlooking weak same-store sales. One concern: the company lowered its full-year same-store sales forecast further, to a decline of 6.5%–7%, and also scaled back its pace of new openings. Can growth fueled by new stores fill the gap enough to support the current valuation?

After integrating the major Commonwealth acquisition, $LPLA cut its latest asset retention estimate from about 90% to about 83%—meaning roughly 7 percentage points more advisor assets are leaving than originally expected. The stock plunged about 15% in a single day after the news.
Strategically, this was supposed to be a “scale for market share” deal: acquire a leading independent broker-dealer (IBD), expand the platform’s asset base, and monetize it through future fee revenue and back-office synergies.
But the financial and sentiment signals point the other way: the acquisition risk everyone fears—“buying the business, then watching the people leave”—is unfolding faster than modeled. Every percentage point drop in retention directly discounts the synergy assumptions and goodwill. The market priced in the deal’s execution risk all at once with a 15% decline.
For a platform brokerage valued on the scale of its advisor assets, what it buys is not a license, but people—and people can leave.
So what is a platform brokerage’s moat built on: its licenses or its people?

$WEN received a non-binding, all-cash take-private proposal from a Trian-led consortium—including its largest franchisee, Flynn Group, as well as BlueFive and Sixth Street—offering $7.35 per share. That represents a premium of about 19%–20% over Tuesday’s closing price and implies a current valuation of roughly $1.4 billion. Trian and its partners already own about 16.3% of the shares. The board has formed an independent special committee to evaluate the proposal; no definitive agreement has been reached. The stock closed up about 15% after the news.

Fundamentally, Wendy’s has become a target precisely because its shares have fallen to a bargain price: same-store sales have declined for six consecutive quarters, the stock has lost about 65% over the past two years, and the company plans to close as many as 358 restaurants this year. Its leadership has also turned over frequently in the past two years.

Sentiment-wise, the closing price remains about 3.8% below the $7.35 offer price. That gap both reflects the market’s enthusiasm for the premium and serves as a reminder that the non-binding proposal still faces hurdles, including special committee review and financing arrangements. Peltz, after all, walked away from a deal in 2022. One takeover offer has put a price tag on a company’s troubles.

For a fast-food chain with six straight quarters of declining same-store sales, would going private be a lifeline—or a bargain buy?

$BLCO reported third-quarter revenue of $1.375 billion, up 7% year over year (+8% at constant currency). GAAP net income swung from a loss of $28 million in the year-ago quarter to a profit of $32 million. Adjusted EBITDA was $325 million, with a 23.6% margin, up 460 basis points from a year ago. The company raised its full-year guidance for the third time, lifting the midpoint of its revenue outlook to about $5.5 billion and its adjusted EBITDA outlook to $1.09–$1.14 billion. Its shares surged about 16% that day.
Fundamentally, all three major segments grew: dry-eye drug MIEBO revenue rose 42%, consumer brand LUMIFY grew 35%, and premium intraocular lenses rose about 70%. Net leverage also fell from 5.7x to 4.1x.
But on closer inspection, nearly all the report’s highlights were in margins, not revenue: the midpoint of full-year EBITDA guidance rose by $65 million, while the revenue midpoint increased by just $10 million. Growth quality still hinges on cost cutting and product mix. There’s also a crack in the financial picture: quarterly interest expense was $95 million, nearly two-thirds of operating income of $155 million, and the interim CEO handover remains unresolved. The market’s 16% cheer seems more like a bet on “marginal improvement” than confirmation of a “trend reversal.”
In a slow-growth field like eye care, how far can a rebound driven by margins go?

$PRCH reported third-quarter consolidated revenue of $143.9 million, up 13% year over year. Breaking it down, excluding Reciprocal, its core-business revenue was $140.8 million, up 22%, including $102.8 million in insurance services revenue, up 39%; adjusted EBITDA (excluding Reciprocal) was $44.5 million, up 116%; and net income was $12.2 million. The company raised its full-year guidance for the third consecutive quarter (with midpoint EBITDA on this basis of $138 million, up 79% year over year). This is a “Rule of 80” profit engine: fixed costs are spread across more business, and the underwriting loss ratio is just 24%. The other set of books is Reciprocal: policy count rose 42% year over year, but average premium per policy fell 2%. Porch collects only management fees, with much of the value reflected in non-admitted assets. Add the planned acquisition of Allied Trust, expected to close in Q1 2027 (at less than 4x EBITDA, but bringing integration and regulatory uncertainties). Shares rose about 21% after hours, and short sellers would need more than 18 trading days to cover. This looks more like a short squeeze triggered by an earnings inflection point than a repricing of the business model.

$GKOS, an ophthalmic medical device company, posted record third-quarter net sales of $211 million, up 58% year over year. U.S. glaucoma revenue rose 47%, and corneal health revenue increased 154%. More importantly, adjusted net income was $28.5 million (EPS of $0.47, versus market expectations for a loss), marking its first adjusted profit in eight years, with gross margin at around 88%. Two new products drove the turnaround: the long-acting glaucoma implant iDose TR fueled 47% growth in U.S. glaucoma revenue, while reimbursement for the corneal cross-linking therapy Epioxa accelerated after its J-code was activated in July, generating about $53 million for the quarter. The company raised its 2026 sales guidance from $680–700 million to $775–785 million and, for the first time, gave an initial 2027 target of around $1 billion. But the same release also spelled out the risks: iDose TR is still awaiting a Medicare local coverage determination (LCD), with the final terms and timing unknown. If reimbursement is narrowed, utilization of this growth engine could be directly affected. Shares rose about 18% after hours.

$KLAC reported revenue of $4.14 billion in its latest quarter, up 28.9% year over year—the tenth consecutive quarter of growth. Even more impressive was its guidance: a midpoint of about $4.7 billion in revenue for the December quarter, implying 42.5% year-over-year growth. That’s acceleration, not deceleration. As the world’s leading supplier of semiconductor process-control equipment, its orders are directly tied to three major AI growth drivers: advanced process nodes, HBM capacity expansion, and advanced Chiplet packaging. It generated $1.53 billion in operating cash flow that quarter, with a free-cash-flow margin of 32.3%, making it one of the few parts of the current AI infrastructure buildout that reliably generates cash. But from another perspective, KLA has no end-market demand of its own; its entire runway depends on capital spending by wafer fabs and hyperscalers. In the same week, capital spending by several giants in the previous quarter came in unusually below analysts’ expectations, putting a pause on concerns that “AI is only burning cash, not generating returns”—but also underscoring that if customers tighten their purse strings, equipment makers’ high growth will be among the first things cut. The stock rose only about 3.2% after hours, suggesting the market may already be pricing in the cyclical nature of these impressive results.

Chipotle’s profits came in below expectations this quarter, but comparable-store sales posted positive growth for the third consecutive quarter—a report card showing that “revenue growth is bumpy, but customer traffic is holding up.”

$CMG’s latest earnings per share fell short of expectations, but same-store sales recorded positive growth for the third quarter in a row, suggesting that its core customer traffic and repeat business remain intact. For a brand driven by the efficiency of each individual location, that’s a more telling sign of health than one quarter’s profits.

The warning signs are on the cost and profit fronts: rising food and labor costs have squeezed margins, while the pace of new store openings and cautious consumer spending have raised doubts about whether “growth in volume can ultimately translate into profits.” From a valuation perspective, the premium for high growth was built on rising same-store sales and margins. Once margins fall behind, a valuation reset can come before revenue does.

Which matters more to you: the resilience shown by Chipotle’s three consecutive quarters of positive growth in customer traffic, or the risk that rising costs will continue to erode profits?

UnitedHealth fell nearly 20% in a single day. The problem wasn’t the quarter that just ended, but its guidance for next year.

$UNH Its latest quarterly results actually showed profits slightly above expectations, yet the stock plunged about 19% in a single day. What really concerned the market was the company’s outlook for next year’s revenue, which came in well below Wall Street expectations. Combined with tight expectations for U.S. Medicare Advantage rates, this cast a shadow over the entire healthcare sector, dragging down peers such as Humana, Elevance, and CVS.

Fundamentally, this is a classic split between “decent current results and a weakening outlook”: insurance underwriting profits are being squeezed by both reimbursement rates and the volume of medical care, while regulators’ decisions on MA rates have lowered the ceiling for next year’s profits. Investors voted with their feet, repricing some of the valuation premium previously attached to healthcare stocks as defensive plays.

When a healthcare insurance leader long considered defensive plunges on its guidance, are you more worried about the company’s fundamentals or the headwinds from healthcare policy overall?

Microsoft once again outperformed this quarter, powered by cloud and AI—but the premium investors are willing to pay for growth is being repriced by capital spending.

$MSFT In its latest quarterly results, Microsoft beat expectations on both revenue and profit. Cloud growth continued to serve as the engine, and the stock briefly rose about 4% after hours. Among the big tech companies, this is another sign that “AI investment is starting to translate into revenue”—demand for Intelligent Cloud, GitHub Copilot, and Azure AI-related services remains the most reliable growth driver.

But there are two readings pointing the other way. First, the widening gap between free cash flow and capital spending: infrastructure spending to expand training and inference capacity continues to climb, putting pressure on cash conversion. Second, the valuation already reflects high expectations, so even marginal changes in Azure growth or capex guidance could amplify volatility. Microsoft’s business is getting stronger, but the price investors are paying for that strength is rising too.

How much longer do you think Microsoft’s “cloud + AI” momentum can sustain its premium valuation?

Spot $SOL ETFs are making a flurry of launches this week, opening another door for mainstream investors.

From October 28 to 29, several spot Solana exchange-traded products are set to begin trading in succession: Bitwise’s SOL ETF, Canary’s LTC ETF, and an HBAR ETF launch first on the 28th, followed by Grayscale’s SOL ETF on the 29th. Bloomberg ETF analyst Eric Balchunas had previously flagged these dates. Following Bitcoin and Ethereum, regulated single-asset crypto products that can be bought and sold through traditional brokerage accounts are now extending their reach to more major blockchains.

From a capital-flow perspective, these products lower the barriers for institutions and passive investors to gain direct exposure without self-custody, which could support greater liquidity over the long term. But structurally, spot ETFs won’t automatically improve SOL’s network revenue or fee consumption—the token’s value will ultimately depend on on-chain activity and the scale of stablecoins and DeFi. An ETF is an entry point, not a fundamental driver.

Now that institutions can buy SOL with a single click, just like a stock, do you place more value on the regulated access it provides, or worry about the gap between “being able to buy” and “being worth buying”?

On-chain Treasuries are no longer just for holding and transferring—they can now serve as collateral while continuing to earn interest. This business is quietly moving from concept to production.

Traditional financial institutions hold large amounts of U.S. Treasuries that sit idle outside of collateral use. A September Citi survey found that 77% of institutions surveyed expect to use some form of tokenized collateral in 2026, while around 25% of collateral assets remain idle and yield nothing due to operational barriers. Bringing Treasuries on-chain so they can both serve as collateral and earn interest is one of the most practical real-world applications emerging in the RWA (real-world asset) sector.

On October 27, Lynq and ZeroBeta connected this mechanism on AVAX: institutions can use tokenized U.S. Treasuries as collateral for secured lending and digital asset trading margin, while continuing to earn interest through Lynq’s collateral-locking and real-time yield technology—without moving the assets off-network. Lynq was co-founded by Arca Labs, Tassat, and tZERO, and is operated by SEC-registered tZERO Securities. The platform has more than $89 million in assets under custody and serves over 40 institutions. Earlier this month, BNY and Citadel Securities also completed a financing transaction using tokenized Treasuries.

From holding to yield-bearing collateral, tokenized Treasuries are taking on-chain institutional infrastructure a step forward. For public blockchains like AVAX that support regulated financial applications, the real question is not short-term price action, but whether they can meet traditional capital’s demand for auditable, yield-bearing, collateralizable on-chain assets. Are you bullish on the potential of RWA collateral, or do you think institutional adoption of on-chain assets is still stuck in the pilot phase?

Record sales, revenue up 42%, adjusted EBITDA topping $800 million—Carvana put on an impressive show this quarter, but two underlying signals may give bulls pause.

Used-car e-commerce company Carvana sold 217,000 retail units in the third quarter, up 39% year over year. Revenue reached $8.04 billion, up 42%, while GAAP net income nearly doubled to $483 million from $263 million a year earlier (earnings per share of $0.40). Adjusted EBITDA also hit a record $800 million. Adding to the good news, the U.S. Securities and Exchange Commission (SEC) closed a previously disclosed investigation without taking enforcement action, and the stock briefly jumped about 10% after hours.

Beneath the strong results, though, are two cracks. First, gross profit per unit (GPU) came under pressure: total GPU fell to $6,997 from $7,362 a year earlier (down $410 to $7,093 on a non-GAAP basis). The company attributed part of the decline to proactively lowering customer loan rates to gain market share. Second, Carvana announced that starting in 2027 it will primarily report results on a GAAP basis, and that it will stop issuing quarterly and annual forward guidance after the fourth quarter of 2026. The growth story is strong, but the company is voluntarily giving up some transparency.

With the broader industry flat, Carvana’s double-digit growth, driven by market-share gains, is a real achievement. But falling GPU and the end of guidance mean that its valuation in the next phase will depend on whether it can grow scale and margins at the same time. Which matters more to you: its accelerating market-share gains, or the warning signs of thinning gross profit and less information?

Adjusted earnings and full-year guidance both rose, yet the stock edged lower after hours—FedEx’s first earnings report under its reset fiscal year tells two different stories.

After moving its fiscal year-end from May 31 to December 31 and spinning off FedEx Freight, the company reported its first quarter under the reset fiscal calendar. For the third quarter ended September 30, adjusted earnings per share came in at $3.74, well above expectations of $3.36. Revenue of $22.86 billion also beat the $22.42 billion estimate. FedEx raised its adjusted EPS guidance for calendar 2026 to $18.00–$18.60, up from $16.90–$18.10, and lifted its revenue growth forecast from 11% to approximately 12%.

But under GAAP, quarterly net income was just $290 million, or $1.21 per share, far below the $645 million, or $2.73 per share, reported a year earlier. The gap was almost entirely due to a one-time write-down: an equity investment retained after the Freight spin-off incurred a loss of approximately $1.2 billion this quarter, partly offset by a $627 million gain on debt extinguishment. Operations were actually improving: package yields and volumes both rose, the adjusted operating margin expanded from 5.1% to 5.3%, and adjusted free cash flow was positive.

So this is not a story of deteriorating operations, but of a disconnect in how the results are reported: the market is focused on GAAP earnings being more than halved, while overlooking record adjusted earnings and raised guidance. As a logistics giant shifts its fiscal year back to the calendar year, perhaps the most important thing to watch in its first report is not year-over-year net income, but its underlying cash-generating ability after optimizing its network. Which set of books do you trust more?